Some are short-acting (requiring daily administration), whilst others are long-acting formulations given once weekly
Heres What the Science Suggests Article at a Glance: GLP-1 is a natural hormone that controls blood sugar, appetite and fullness
at the first sign of rapid appetite return or rising weight trend
Nature 556 , 360365 (2018): Lee, H.-E
This step helps me avoid confusion later
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Published May 11, 2025 N Engl J Med 2025;393:26-36 DOI: 10.1056/NEJMoa2416394 Abstract Background Methods In this phase 3b, open-label, controlled trial, adult participants with obesity but without type 2 diabetes were randomly assigned in a 1:1 ratio to receive the maximum tolerated dose of tirzepatide (10 mg or 15 mg) or the maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg) subcutaneously once weekly for 72 weeks